Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-29

Clinical Trial Update: Role of Sympathetic Activation in Ischemia Reperfusion Injury [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the role of sympathetic activation in ischemia reperfusion injury has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal Perth Hospital | Conditions: Central Sympathetic Nervous System Diseases | Phase 4 | Status: COMPLETED